Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Acromegaly
Related studies linked through entity extraction aliases.
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly
- Status
- COMPLETED
- Phase
- PHASE3
Estrogen Treatment in Acromegalic Women
- Status
- UNKNOWN
- Phase
- PHASE2
Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas
- Status
- TERMINATED
- Phase
- PHASE4
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Acromegaly Treated With Either Lanreotide or Octreotide
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly
- Status
- COMPLETED
- Phase
- PHASE3
Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Lanreotide Autogel (60, 90 or 120 mg) in Acromegalic Patients
- Status
- COMPLETED
- Phase
- PHASE3
Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency
- Status
- COMPLETED
- Phase
- NA
Octreotide Efficacy and Safety in First-line Acromegalic Patients
- Status
- COMPLETED
- Phase
- PHASE4
An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly
- Status
- COMPLETED
- Phase
- PHASE2
Canadian Pegvisomant Compassionate Study In Acromegalic Patients
- Status
- COMPLETED
- Phase
- PHASE4
Somatuline Autogel: Acromegaly Self/Partner Injection Study
- Status
- COMPLETED
- Phase
- PHASE4
Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction
- Status
- COMPLETED
- Phase
- PHASE4
Long Term Study With B2036-PEG
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Octreotide Long Acting Release (LAR) in Treatment Naïve Acromegalic Patients
- Status
- COMPLETED
- Phase
- PHASE3
Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly
- Status
- COMPLETED
- Phase
- PHASE4